Clinical Trial Update: Inhaled Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) in Hereditary Pulmonary Alveolar Proteinosis (PAP) [Phase 2]

View source ↗

Summary

Phase 2 trial investigating inhaled GM-CSF for hereditary pulmonary alveolar proteinosis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Pulmonary Alveolar Proteinosis

Drugs mentioned

• GM-CSF (granulocyte-macrophage colony-stimulating factor)

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Hereditary Pulmonary Alveolar Proteinosis | Phase 2 | Status: COMPLETED | Results posted: 2020-09-01